ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 190 filers reported holding ABCELLERA BIOLOGICS INC in Q3 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $19,231,533 | -28.8% | 4,180,768 | 0.0% | 0.41% | -16.4% |
| Q2 2023 | $27,007,761 | -14.3% | 4,180,768 | 0.0% | 0.49% | -21.0% |
| Q1 2023 | $31,522,991 | -25.6% | 4,180,768 | 0.0% | 0.62% | -23.6% |
| Q4 2022 | $42,351,180 | +2.4% | 4,180,768 | 0.0% | 0.81% | +5.5% |
| Q3 2022 | $41,348,000 | -12.4% | 4,180,768 | -5.6% | 0.77% | -10.2% |
| Q2 2022 | $47,188,000 | +15.8% | 4,430,768 | +6.0% | 0.86% | +29.3% |
| Q1 2022 | $40,762,000 | -31.8% | 4,180,768 | 0.0% | 0.66% | -14.0% |
| Q4 2021 | $59,785,000 | -28.6% | 4,180,768 | 0.0% | 0.77% | -16.5% |
| Q3 2021 | $83,783,000 | -38.8% | 4,180,768 | -32.8% | 0.92% | -33.5% |
| Q2 2021 | $136,906,000 | -50.8% | 6,223,019 | -24.1% | 1.38% | -46.8% |
| Q1 2021 | $278,498,000 | -17.6% | 8,200,768 | -2.4% | 2.60% | -12.0% |
| Q4 2020 | $338,047,000 | – | 8,400,768 | – | 2.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $37,320,000 | 92.58% |
| Gruss & Co., LLC | 308,570 | $3,052,000 | 26.27% |
| Founders Fund Growth Management, LLC | 407,017 | $4,025,000 | 11.55% |
| Belmont Capital, LLC | 510,000 | $5,044,000 | 5.95% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $40,599,000 | 5.05% |
| GUARDIAN CAPITAL ADVISORS LP | 3,736,414 | $40,129,000 | 5.01% |
| Intellectus Partners, LLC | 1,091,505 | $10,795,000 | 3.84% |
| ArchPoint Investors | 617,213 | $6,104,000 | 2.49% |
| BRANDYWINE MANAGERS, LLC | 56,976 | $563,000 | 1.85% |
| Casdin Capital, LLC | 1,650,000 | $16,319,000 | 1.07% |